Cargando…

Colon Cancer Cells Gene Expression Signature As Response to 5- Fluorouracil, Oxaliplatin, and Folinic Acid Treatment

5-FU cytotoxicity mechanism has been assigned both to the miss-incorporation of fluoronucleotides into RNA and DNA and to the inhibition of thymidylate synthase. 5-FU is one of the most widely used chemotherapeutic drugs, although it has severe side effects that may vary between patients. Pharmacoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Negrei, Carolina, Hudita, Ariana, Ginghina, Octav, Galateanu, Bianca, Voicu, Sorina Nicoleta, Stan, Miriana, Costache, Marieta, Fenga, Concettina, Drakoulis, Nikolaos, Tsatsakis, Aristidis M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917556/ https://www.ncbi.nlm.nih.gov/pubmed/27445811 http://dx.doi.org/10.3389/fphar.2016.00172

Ejemplares similares

Impact of multicellular tumor spheroids as an in vivo-like tumor model on anticancer drug response
por: GALATEANU, BIANCA, et al.
Publicado: (2016)

Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients
por: Ginghină, Octav, et al.
Publicado: (2021)

In Vitro Cytotoxic Protective Effect of Alginate-Encapsulated Capsaicin Might Improve Skin Side Effects Associated with the Topical Application of Capsaicin
por: Hudita, Ariana, et al.
Publicado: (2021)

Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer
por: Radu, Ionut-Cristian, et al.
Publicado: (2017)

Bio- and Hemo-Compatible Silk Fibroin PEGylated Nanocarriers for 5-Fluorouracil Chemotherapy in Colorectal Cancer: In Vitro Studies
por: Hudiță, Ariana, et al.
Publicado: (2021)

Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer
por: Radu, Ionut Cristian, et al.
Publicado: (2019)

In Vitro Interaction of Doxorubicin-Loaded Silk Sericin Nanocarriers with MCF-7 Breast Cancer Cells Leads to DNA Damage
por: Radu, Ionuț-Cristian, et al.
Publicado: (2021)

Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification
por: Ginghina, Octav, et al.
Publicado: (2022)

Worldwide legislative challenges related to psychoactive drugs
por: Negrei, Carolina, et al.
Publicado: (2017)

Chemoprevention of Colorectal Cancer by Dietary Compounds
por: Costea, Teodora, et al.
Publicado: (2018)

Liquid biopsy in lung cancer management
por: Irofei Zamfir, Maria-Anca, et al.
Publicado: (2022)

Novel chitosan and bacterial cellulose biocomposites tailored with polymeric nanoparticles for modern wound dressing development
por: Stanescu, Paul-Octavian, et al.
Publicado: (2021)

Allergy in Cancer Care: Antineoplastic Therapy-Induced Hypersensitivity Reactions
por: Galateanu, Bianca, et al.
Publicado: (2023)

Fluorouracil/folinic acid/oxaliplatin: Various toxicities: 2 case reports
Publicado: (2021)

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer
por: Conroy, T, et al.
Publicado: (2008)

Polymer Materials for Drug Delivery and Tissue Engineering
por: Hudiță, Ariana, et al.
Publicado: (2023)

Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity
por: Fischel, J L, et al.
Publicado: (2002)

Applications of Polymers for Organ-on-Chip Technology in Urology
por: Galateanu, Bianca, et al.
Publicado: (2022)

Modulation of Adipogenic Conditions for Prospective Use of hADSCs in Adipose Tissue Engineering
por: Galateanu, Bianca, et al.
Publicado: (2012)

Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines
por: Fischel, J-L, et al.
Publicado: (2001)

Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer
por: Jonker, D., et al.
Publicado: (2006)

Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment
por: Zoetemelk, Marloes, et al.
Publicado: (2020)

Sericin Enhances the Bioperformance of Collagen-Based Matrices Preseeded with Human-Adipose Derived Stem Cells (hADSCs)
por: Dinescu, Sorina, et al.
Publicado: (2013)

Management of rheumatoid arthritis: Impact and risks of various therapeutic approaches
por: NEGREI, CAROLINA, et al.
Publicado: (2016)

Folinic Acid, Fluorouracil, and Oxaliplatin Therapy for Recurrent Esophageal Cancer with Syndrome of Inadequate Antidiuretic Hormone Secretion (SIADH) After Preoperative Cisplatin/5-Fluorouracil Therapy
por: Futai, Ryoko, et al.
Publicado: (2022)

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
por: Garufi, C, et al.
Publicado: (2003)

Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer
por: Kim, Han Jo, et al.
Publicado: (2011)

Perilipin Expression Reveals Adipogenic Potential of hADSCs inside Superporous Polymeric Cellular Delivery Systems
por: Dinescu, Sorina, et al.
Publicado: (2014)

Biocompatibility Assessment of Novel Collagen-Sericin Scaffolds Improved with Hyaluronic Acid and Chondroitin Sulfate for Cartilage Regeneration
por: Dinescu, Sorina, et al.
Publicado: (2013)

Dual NGS Comparative Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Samples of Non-Small Cell Lung Carcinoma (NSCLC)
por: Buburuzan, Laura, et al.
Publicado: (2022)

5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment?
por: Kerr, D. J.
Publicado: (1989)

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer
por: Lordick, F, et al.
Publicado: (2005)

Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
por: Chao, Y, et al.
Publicado: (2004)

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)
por: Souglakos, J, et al.
Publicado: (2006)

Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
por: Gonzalez, M A, et al.
Publicado: (2003)

A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma
por: Correale, P, et al.
Publicado: (2004)

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial
por: Messager, Mathieu, et al.
Publicado: (2016)

Spontaneous Aortic Haematoma in a Patient Receiving Adjuvant Folinic Acid, 5-Fluorouracil, Irinotecan, and Oxaliplatin Chemotherapy Following Resection of a Pancreatic Adenocarcinoma
por: Dacie, Ruth, et al.
Publicado: (2020)

Update on radionuclide therapy in oncology
por: Nitipir, Cornelia, et al.
Publicado: (2017)

Combined effects of 5-Fluorouracil, Folinic acid and Oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy
por: Prete, Salvatore P, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_n470dau520h0ibuch921vtvnqp